Responsive Image

 

 

Responsive Image

Enfermedades respiratorias

Líneas de investigación

Asma. Patología medioambiental y ocupacional
Circulación pulmonar
Enfermedad pulmonar intersticial difusa
Enfermedad pulmonar obstructiva crónica
Infección respiratoria

 

Coordinador/a del grupo



Miembros del grupo

  Myriam Aburto Barrenechea
 
 
  Susana Aizpiri Rivero
 
 
  Lander Altube Urrengoechea
 
 
  Amaia Aramburu Ojembarrena
 
 
  Juan Ignácio Arriaga Lariz
 
 
  Itziar Arrizubieta Basterrechea
 
 
  Aitor Ballaz Quincoces
 
 
  Lucía Esperanza Barriuso Carazo
 
 
  Olaia Bronte Moreno
 
 
  Leyre Chasco Eguilaz
 
 
  Sandra Dorado Arenas
 
 
  Mikel Egurrola Izquierdo
 
 
  Pedro Pablo España Yandiola
 
 
  Amaia García Loizaga
 
 
  María Inmaculada Gorordo Unzueta
 
 
  Maider Intxausti Urrutibeaskoa
 
 
  Pablo Latimori Cardach
 
 
  Aizea Mardones Charroalde
 
 
  María Teresa Martínez Ramírez
 
 
  Francisco Javier Moraza Cortés
 
 
  Mikel Oribe Ibáñez
 
  Silvia Pascual Erquicia
 
 
  Julio Pérez Izquierdo
 
 
  Mónica Elizabeth Ponce Sánchez
 
 
  Amaia Sagarna Aguirrezabala
 
 
  Raquel Sánchez Juez
 
 
  Jose Miguel Tirapu Puyal
 
 
  María Dolores Tovar Echevarria
 
 
  Ane Uranga Echeverria
 
 
  Isabel Inés Urrutia Landa
 
 
  Txomin Zabala Hernández
 
 
  Amaia Artaraz Ereño
 
 
  Jesús Camino Buey
 
 
  Adolfo Lahuerta Castro
 
 
  Antonio Manuel Pérez Llerandi
 
 
  Cristina Sancho Sainz
 
 
  Cristina Sancho Sainz
 
 
  Mónica Nieves Ermecheo
 
 
  Marta Arias Martínez
 
  Marta Arias Martínez
 
 

Publicaciones del grupo

Esteban C, Arostegui I, Aramburu A, Moraza J, Aburto M, Aizpiri S, et al. Changes in health-related quality of life as a marker in the prognosis in COPD patients. ERJ Open Res. 2022; 8(1). DOI:10.1183/23120541.00181-2021.

Esteban C, Villanueva A, García Gutierrez S, Aramburu A, Gorordo I, Quintana JM, et al. COPD in SARS-CoV-2 pandemic. Baseline characteristics related to hospital admissions. Expert Rev Respir Med. 2022; 16(4): 477-484. DOI:10.1080/17476348.2022.2031985.

Urrechaga E, Ponga C, Fernandez M, Espana PP, Haider RZ, Aguirre U. Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department. Clin Chem Lab Med. 2022; 60(5): 104-107. DOI:10.1515/cclm-2021-1309.

Echevarria Uraga JJ, Del Cura Allende G, Armendariz Tellitu K, Berastegi Santamaria C, Egurrola Izquierdo M, Anton Ladislao A. Complications and diagnostic accuracy of CT-guided 18G tru-cut versus end-cut percutaneous core needle biopsy of solitary solid lung nodules. Diagn Interv Radiol. 2022; 28(1): 58-64. DOI:10.5152/DIR.2021.20462.

Uranga A, Villanueva A, Lafuente I, Gonzalez N, Legarreta MJ, Aguirre U, et al. [Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study]. Rev Clin Esp. 2022; 222(1): 22-30. DOI:10.1016/j.rce.2021.04.007.

Quintana JM, Anton Ladislao A, Orive M, Aramburu A, Iriberri M, Sánchez R, et al. Predictors of short-term COPD readmission. Intern Emerg Med. 2022; 17(5): 1481-1490. DOI:10.1007/s11739-022-02948-4.

Figueira Goncalves JM, Golpe R, Esteban C, Amado Diago C, Garcia Talavera I, Ramos Izquierdo C. [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?. Arch Bronconeumol. 2022; 58(4): 364-366. DOI:10.1016/j.arbres.2021.07.020.

Ruiz Sada P, Mazzolai L, Braester A, Ballaz A, Madridano O, Accassat S, et al. Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation. Br J Haematol. 2022; 197(4): 489-496. DOI:10.1111/bjh.18124.

Herrero EP, Etxebarria AV, Ojembarrena AA, Salmeron PP, Lopez JMQ, Gonzalez CE, et al. Influence of the COPD Assessment Test respiratory item score on the decision to hospitalize patients with disease exacerbation in a hospital emergency department. Emergencias. 2022; 34(2): 95-102

Golpe R, Figueira Goncalves JM, Esteban C, Amado Diago CA, Aramburu A, Garcia Talavera I, et al. [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events. Arch Bronconeumol. 2022; 58(5): 451-453. DOI:10.1016/j.arbres.2021.11.016.

Espana Yandiola PP, Uranga Etxeberria A, Artaraz Ereno A, Jodar Samper A. Diagnostic and therapeutic approach to occupational pneumonia. Rev Esp Quimioter. 2022; 35 Suppl 1. DOI:10.37201/req/s01.19.2022.

Moitra S, Carsin A, Abramson MJ, Accordini S, Amaral AFS, Anto J, et al. Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS. Thorax. 2022. DOI:10.1136/thoraxjnl-2021-217867.

Pinedo Otaola S, Sanmartin Cuevas V, Fernandez Fernandez de Leceta Z, Perez Iglesias N, Lopez De Munain Berganzo A, Azkuenaga Fernandez M, et al. [Impact of the COVID-19 on health of critical patient]. Rehabilitacion (Madr). 2022. DOI:10.1016/j.rh.2022.02.005.

Garcia Gutierrez S, Esteban Aizpiri C, Lafuente I, Barrio I, Quiros R, Quintana JM, et al. Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19. Sci Rep. 2022; 12(1): 7097-7097. DOI:10.1038/s41598-022-09771-z.

Menendez R, Mendez R, Gonzalez Jimenez P, Zalacain R, Ruiz LA, Serrano L, et al. Early recognition of low-risk SARS-CoV-2 pneumonia: A model validated with initial data and IDSA/ATS minor criteria. Chest. 2022; 162(4): 768-781. DOI:10.1016/j.chest.2022.05.013.

Garcia Gutierrez S, Esteban Aizpiri C, Lafuente I, Barrio I, Quiros R, Quintana JM, et al. Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (vol 12, 7097, 2022). Sci Rep. 2022; 12(1): 7811-7811. DOI:10.1038/s41598-022-12247-9.

Quirce S, Trigueros JA, Ausin P, Munoz Cano R, Ramirez Hernandez M, Gonzalez Barcala FJ, et al. Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force. J Invest Allergol Clin Immunol. 2022. DOI:10.18176/jiaci.0833.

Pascual S, Dorado S, Urrutia I. Physical Activity and Asthma. Arch Bronconeumol. 2022; 58(11): 733-734. DOI:10.1016/j.arbres.2022.03.028.

Barlas RS, Clark AB, Loke YK, Kwok CS, Angus DC, Uranga A, et al. Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort. Respir Med. 2022; 200: 106884-106884. DOI:10.1016/j.rmed.2022.106884.

Cabrera Lopez C, Urrutia Landa I, Jimenez Ruiz CA. Reply to Inhalation Devices and Climatic Change. Arch Bronconeumol. 2022; 58(3): 288-288. DOI:10.1016/j.arbres.2021.07.009.

Perez de Llano LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, Tejedor Alonso MA, Malanda NM, et al. First line versus second line use of reslizumab in severe uncontrolled asthma. J Invest Allergol Clin Immunol. 2022: 0-0. DOI:10.18176/jiaci.0839.

Cabrera Lopez C, Urrutia Landa I, Jimenez Ruiz CA. [Translated article] Reply to "Inhalation Devices and Climatic Change". Arch Bronconeumol. 2022; 58(3): 288-288. DOI:10.1016/j.arbres.2021.07.015.

Figueira Goncalves JM, Golpe R, Esteban C, Garcia Bello MA, Blanco Cid N, Aramburu A, et al. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study. Clin Respir J. 2022; 16(7): 504-512. DOI:10.1111/crj.13518.

Amado Diago CA, Figueira Goncalves JM, Golpe R, Esteban C, Garcia Talavera I, Garcia Martin S. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria. Arch Bronconeumol. 2022. DOI:10.1016/j.arbres.2022.06.009.

Gall XM, Dominguez Ortega J, Pascual S, Lopez CC, Resler G, Nuevo J, et al. Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study. J Asthma. 2022: 1-10. DOI:10.1080/02770903.2022.2103428.

Golpe R, Figueira Goncalves JM, Amado Diago CA, Exposito Marrero A, Gonzalez Ramos L, Dacal Rivas D, et al. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk. Lung. 2022; 200(5): 601-607. DOI:10.1007/s00408-022-00565-8.

Tabernero E, Rodrigo T, Garros J, Altube L, Garay E, Medina J-F, et al. TB in the elderly: clinical features and outcomes. Int J Tuberc Lung Dis. 2022; 26(9): 842-849. DOI:10.5588/ijtld.22.0010.

Serrano L, Ruiz LA, Perez S, Espana PP, Gomez A, Cilloniz C, et al. ESTIMATING THE RISK OF BACTERAEMIA IN HOSPITALISED PATIENTS WITH PNEUMOCOCCAL PNEUMONIA. J Infect. 2022. DOI:10.1016/j.jinf.2022.09.017.

Uranga A, Urrechaga E, Aguirre U, Intxausti M, Ruiz Martinez C, Lopez de Goicoechea MJ, et al. Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia. Arch Bronconeumol. 2022. DOI:10.1016/j.arbres.2022.08.011.

Trujillo Santos J, Farge Bancel D, Pedrajas JM, Gomez Cuervo C, Ballaz A, Braester A, et al. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study. Res Pract Thromb Haemost. 2022; 6(4). DOI:10.1002/rth2.12736.

Perpina M, Gomez Bastero A, Trisan A, Martinez Moragon E, Alvarez Gutierrez FJ, Urrutia I, et al. Expert consensus recommendations for the management of asthma in older adults. Med Clin. 2022; 159(1). DOI:10.1016/j.medcli.2021.04.028.

Pascual Guardia S, Amati F, Marin Corral J, Aliberti S, Gea J, Soni NJ, et al. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Arch Bronconeumol. 2022. DOI:10.1016/j.arbres.2022.09.005.

Soler Cataluna JJ, Puente Maestu L, Roman Rodriguez M, Esteban C, Gea J, Bernabeu Mora R, et al. Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease. Int J COPD. 2022; 17: 2835-2846. DOI:10.2147/COPD.S381427.

Uranga A, Artaraz A, Bilbao A, Quintana JM, Arriaga I, Intxausti M et al. Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia. BMC Pulm Med. 2021; 21(1): 21-21. DOI:10.1186/s12890-020-01378-2.

Espana PP, Bilbao A, Garcia Gutierrez S, Lafuente I, Anton Ladislao A, Villanueva A et al. Predictors of mortality of COVID-19 in the general population and nursing homes. Intern Emerg Med. 2021; 16(6): 1487-1496. DOI:10.1007/s11739-020-02594-8.

Plaza V, Trigueros JA, Cisneros C, Dominguez Ortega J, Cimbollek S, Fernandez S et al. The Importance of Small Airway Dysfunction in Asthma. The GEMA-FORUM III Task Force. J Invest Allergol Clin Immunol. 2021: 0-0. DOI:10.18176/jiaci.0686.

Cabrera Lopez C, Urrutia Landa I, Jimenez Ruiz CA. SEPAR's Year: Air Quality. SEPAR Statement on Climate Change. Arch Bronconeumol. 2021; 57(5): 313-314. DOI:10.1016/j.arbres.2021.03.003.

Torres A, Menendez R, Espana PP, Fernandez Villar JA, Marimon JM, Cilloniz C et al. The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011-2018. Clin Infect Dis. 2021; 73(6): 1075-1085. DOI:10.1093/cid/ciab307.

Crespo Lessmann A, Bernal S, Del Rio E, Rojas E, Martinez Rivera C, Marina N et al. Association of the CFTR gene with asthma and airway mucus hypersecretion. PLoS One. 2021; 16(6): 251881-251881. DOI:10.1371/journal.pone.0251881.

Russell MA, Dharmage S, Fuertes E, Marcon A, Carsin AE, Erquicia SP et al. The effect of physical activity on asthma incidence over 10 years: population-based study. ERJ Open Res. 2021; 7(1). DOI:10.1183/23120541.00970-2020.

Barca Hernando M, Munoz Martin AJ, Rios Herranz E, Garcia Escobar I, Beato C, Font C et al. Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis. Cancers (Basel). 2021; 13(11). DOI:10.3390/cancers13112517.

Urrechaga E, Mugertza G, Fernandez M, Espana PP, Aguirre U. Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection. Scand J Clin Lab Invest. 2021; 81(5): 1-7. DOI:10.1080/00365513.2021.1929445.

Cabrera Lopez C, Urrutia Landa I, Jimenez Ruiz CA. Climate change: SEPAR's responsibilities. Arch Bronconeumol. 2021; 57(6): 381-382. DOI:10.1016/j.arbr.2021.04.007.

Lopez Campos JL, Jimenez Ruiz CA, Meneses Petersen ED, Rabade Castedo C, Asensio Sanchez S, Vaquero Lozano P et al. Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200. Arch Bronconeumol. 2021. DOI:10.1016/j.arbres.2021.05.013.

Bermudo G, Suarez Cuartin G, Rivera Ortega P, Rodriguez Portal JA, Sauleda J, Nunez B et al. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. Arch Bronconeumol. 2021. DOI:10.1016/j.arbres.2021.03.018.

Esteban C, Antón A, Moraza J, Iriberri M, Larrauri M, Mar J et al. Cost-effectiveness of a telemonitoring program (telEPOC program) in frequently admitted chronic obstructive pulmonary disease patients. J Telemed Telecare. 2021. DOI:10.1177/1357633X211037207.

Tabernero E, Ruiz LA, Espana PP, Mendez R, Serrano L, Santos B, et al. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences. Infection. 2022; 50(1): 179-189. DOI:10.1007/s15010-021-01684-9.

Adeloye D, Elneima O, Daines L, Poinasamy K, Quint JK, Walker S et al. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Resp Med. 2021; 9(12): 1467-1478. DOI:10.1016/S2213-2600(21)00286-1.

Uranga A, Villanueva A, Lafuente I, Gonzalez N, Legarreta MJ, Aguirre U et al. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study. Rev Clin Esp (Barc). 2021; 222(1): 22-30. DOI:10.1016/j.rceng.2021.04.009.

de Llano LP, Golpe R, Perez Ortiz D, Menendez R, Yandiola PPE, Artaraz A et al. [Early initiation of corticosteroids might be harmful in patients hospitalized with COVID-19 pneumonia: A multicenter propensity score analysis.]. Arch Bronconeumol. 2021; 58(3): 281-283. DOI:10.1016/j.arbres.2021.10.001.

Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler Laporte G, Maya Miles D et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021; 131(23). DOI:10.1172/JCI152386.

COVID 19 Host Genetics I. Mapping the human genetic architecture of COVID-19. Nature. 2021; 600(7889): 472-477. DOI:10.1038/s41586-021-03767-x.

Fernandez LS, Iturriaga LAR, Yandiola PPE, Ocana RM, Fernandez SP, Huget ET et al. BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES. Int J Infect Dis. 2021; 115: 39-47. DOI:10.1016/j.ijid.2021.11.023.

Adeloye D, Agarwal D, Barnes PJ, Bonay M, van Boven JF, Bryant J et al. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. J Glob Health. 2021; 11. DOI:10.7189/jogh.11.15003.

Garrote Corral S, Silva Fernandez L, Seoane Mato D, Guerra Rodriguez M, Aburto M, Castaneda S et al. Screening of interstitial lung disease in patients with rheumatoid arthritis: A systematic review. Reumatol Clin (Engl Ed). 2021. DOI:10.1016/j.reumae.2021.07.002.

Golpe R, Figueira GonCalves JM, Amado CA, Martin Audera P, Esteban C, Garcia Talavera I et al. A new, three-dimensional approach to the GOLD COPD assessment tool. Respir Med Res. 2021; 81. DOI:10.1016/j.resmer.2021.100879.

Mendez R, Gonzalez Jimenez P, Latorre A, Serrano L, Ruiz LA, Zalacain R et al. Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA3659.

Iturriaga L, Fernandez LS, Quero BG, Bonilla AG, Fernandez SP, Carasusan AR et al. Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA1749.

Fernandez LS, Iturriaga L, Yandiola P, Ocana RM, Fernandez SP, Huget ET et al. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA1750.

Huguet ET, Iturriaga L, Fernandez LS, Yandiola P, Mendez R, Zorrozua BS et al. COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.OA88.

Expósito Ruiz M, Arcelus JI, Caprini JA, López Espada C, Bura Riviere A, Amado C et al. Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord. 2021; 9(4). DOI:10.1016/j.jvsv.2020.11.017.

Golpe R, Figueira Goncalves JM, Esteban C, Amado Diago CA, Aramburu A, Garcia Talavera I et al. Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events. Arch Bronconeumol. 2021; 58(5): 451-453. DOI:10.1016/j.arbres.2021.11.010.

Figueira Goncalves JM, Golpe R, Esteban C, Amado Diago C, Garcia Talavera I, Ramos Izquierdo C. Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?. Arch Bronconeumol. 2021; 58(4): 364-366. DOI:10.1016/j.arbres.2021.07.001.

Galanaud JP, Trujillo Santos J, Bikdeli B, Di Micco P, Bortoluzzi C, Bertoletti L et al. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry. J Thromb Thrombolysis. 2021; 52(2): 532-541. DOI:10.1007/s11239-020-02347-6.

Orrantia A, Terren I, Pando GA, Gonzalez C, Uranga A, Mazon JJM et al. High frequency of mature CD57+NKG2A-NK cells associate with poor disease progression after autologous hematopoietic stem cell transplantation in multiple myeloma patients. Eur J Immunol. 2021; 51: 271-271

Goncalves JMF, Golpe R, Esteban C, Acosta Sorensen M, Veiga I, Guzman Peralta I. Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC Guideline vs. GOLD. Rev Clin Esp. 2021; 221(9): 536-539. DOI:10.1016/j.rce.2021.01.009.

Aldás I, Menéndez R, Méndez R, España PP, Almirall J, Boderías L, et al. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia. Arch Bronconeumol. 2020; 56(9): 551-558. DOI:10.1016/j.arbres.2019.10.009.

Quezada A, Jiménez D, Bikdeli B, Moores L, Porres Aguilar M, Aramberri M, et al. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism. Int J Cardiol. 2020; 302: 157-163. DOI:10.1016/j.ijcard.2019.11.102.

Artaraz A, Crichton ML, Finch S, Abo Leyah H, Goeminne P, Aliberti S, et al. Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST). Respir Res. 2020; 21(1): 18-18. DOI:10.1186/s12931-019-1272-y.

Aburto M, Perez Izquierdo J, Agirre U, Barredo I, Echevarria Uraga JJ, Armendariz K, et al. Complications and hospital admission in the following 90 days after lung cryobiopsy performed in interstitial lung disease. Respir Med. 2020; 165: 105934-105934. DOI:10.1016/j.rmed.2020.105934.

Peralta GP, Marcon A, Carsin AE, Abramson MJ, Accordini S, Amaral AF, et al. Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study. Thorax. 2020; 75(4): 313-320. DOI:10.1136/thoraxjnl-2019-213880.

Bjornsdottir E, Lindberg E, Benediktsdottir B, Gislason T, Garcia Larsen V, Franklin K, et al. Are symptoms of insomnia related to respiratory symptoms? Cross-sectional results from 10 European countries and Australia. Bmj Open. 2020; 10(4). DOI:10.1136/bmjopen-2019-032511.

Menéndez R, Cilloniz C, España PP, Almirall J, Uranga A, Méndez R, et al. Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update. Arch Bronconeumol. 2020; 56 Suppl 1: 1-10. DOI:10.1016/j.arbres.2020.01.014.

Soldevila N, Toledo D, Ortiz de Lejarazu R, Tamames S, Castilla J, Astray J, et al. Effect of antiviral treatment in older patients hospitalized with confirmed influenza. Antiviral Res. 2020; 178: 104785-104785. DOI:10.1016/j.antiviral.2020.104785.

Pascual Erquicia S, Bernaola Abraira M, Dorado Arenas S, Urrutia Landa I, Arrizubieta Basterrechea I, Bronte Moreno O, et al. Rhinoconjunctivitis and Occupational Asthma due to Buckwheat Flour Allergy. Arch Bronconeumol. 2020; 56(7). DOI:10.1016/j.arbres.2020.02.001.

Bikdeli B, Jimenez D, Muriel A, Barrios D, Ballaz A, Verhamme P, et al. ASSOCIATION BETWEEN REPERFUSION THERAPY AND OUTCOMES IN PATIENTS WITH ACUTE PULMONARY EMBOLISM AND RIGHT HEART THROMBI. J Am Coll Cardiol. 2020; 75(11): 2199-2199

Bikdeli B, Jimenez D, Muriel A, Barrios D, Ballaz A, Verhamme P, et al. Association Between Reperfusion Therapy and Outcomes in Patients with Acute Pulmonary Embolism and Right Heart Thrombi. Eur Resp J. 2020; 56(5). DOI:10.1183/13993003.00538-2020.

Esteban C, Arostegui I, Aramburu A, Moraza J, Najera Zuloaga J, Aburto M, et al. Predictive factors over time of health-related quality of life in COPD patients. Respir Res. 2020; 21(1). DOI:10.1186/s12931-020-01395-z.

de Miguel Diez J, Blasco Esquivias I, Rodriguez Matute C, Bedate Diaz P, Lopez Reyes R, Fernandez Capitan C, et al. Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group). Thromb Res. 2020; 192: 134-140. DOI:10.1016/j.thromres.2020.04.033.

Carsin A, Keidel D, Fuertes E, Imboden M, Weyler J, Nowak D, et al. Regular Physical Activity Levels and Incidence of Restrictive Spirometry Pattern: A Longitudinal Analysis of Two Population-based Cohorts. Am J Epidemiol. 2020. DOI:10.1093/aje/kwaa087.

Serrano L, Ruiz LA, Martinez Indart L, Espana PP, Gomez A, Uranga A, et al. Non-bacteremic pneumococcal pneumonia: general characteristics and early predictive factors for poor outcome. Infect Dis. 2020; 52(9): 603-611. DOI:10.1080/23744235.2020.1772991.

Espana PP, Uranga A, Cilloniz C, Torres A. Q Fever (Coxiella Burnetii). Semin Respir Crit Care Med. 2020; 41(04): 509-521. DOI:10.1055/s-0040-1710594.

Chasco L, Ballaz A, Oribe MA, Artaraz A, Aramburu A, Velasco S, et al. Thrombus in transit. Arch Bronconeumol. 2020; 56(8): 537-539. DOI:10.1016/j.arbres.2020.04.007.

Perez TA, Castillo EG, Ancochea J, Pastor Sanz MT, Almagro P, Martinez Camblor P, et al. Sex differences between women and men with COPD: A new analysis of the 3CIA study. Respir Med. 2020; 171: 106105-106105. DOI:10.1016/j.rmed.2020.106105.

Aburto M, Aguirre U, Arrizubieta MI, Perez Izquierdo J, Bronte O, Gorordo I, et al. Checking Siblings of Idiopathic Pulmonary Fibrosis Patients as a Scheme for Early Disease Detection. Ann Am Thorac Soc. 2020; 18(1): 172-174. DOI:10.1513/AnnalsATS.202002-111RL.

Sanchez Lopez V, Gao L, Ferrer Galvan M, Arellano Orden E, Elias Hernandez T, Jara Palomares L, et al. Differential biomarker profiles between unprovoked venous thromboembolism and cancer. Ann Med. 2020; 52(6): 310-320. DOI:10.1080/07853890.2020.1779956.

Pesce G, Triebner K, van der Plaat DA, Courbon D, Hustad S, Sigsgaard T, et al. Low serum DHEA-S is associated with impaired lung function in women. Eclinicalmedicine. 2020; 23: 100389-100389. DOI:10.1016/j.eclinm.2020.100389.

Pajares V, Nunez Delgado M, Bonet G, Perez Pallares J, Martinez R, Cubero N, et al. Transbronchial biopsy results according to diffuse interstitial lung disease classification. Cryobiopsy versus forceps: MULTICRIO study. PLoS One. 2020; 15(9): 239114-239114. DOI:10.1371/journal.pone.0239114.

Uranga Md A, Artaraz Md A, Bilbao Md A, Quintana Md JM, Arriaga Md I, Intxausti Md M, et al. Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia. BMC Pulm Med. 2020; 20(1): 261-261. DOI:10.1186/s12890-020-01293-6.

Urrechaga E, Aguirre U, Espana PP, Garcia de Guadiana L. Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection. Clin Chem Lab Med. 2020; 59(2): 57-60. DOI:10.1515/cclm-2020-1416.

Lytras T, Beckmeyer Borowko A, Kogevinas M, Kromhout H, Carsin A, Anto JM, et al. Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts. Ann Am Thorac Soc. 2020. DOI:10.1513/AnnalsATS.202002-113OC.

Ruiz LA, Serrano L, Espana PP, Martinez Indart L, Gomez A, Gonzalez B, et al. New-onset atrial fibrillation in patients with pneumococcal pneumonia. Impact of timing and duration on short- and medium-term mortality. J Infect. 2020; 82(1): 67-75. DOI:10.1016/j.jinf.2020.11.005.

Campo P, Soto Campos G, Moreira A, Quirce S, Padilla Galo A, Martinez Moragon E, et al. Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment. Allergy. 2020. DOI:10.1111/all.14668.

Cabrera Lopez C, Urrutia Landa I, Jimenez Ruiz CA. Climate Change: SEPAR's Responsibilities. Arch Bronconeumol. 2020; 57(6): 381-382. DOI:10.1016/j.arbres.2020.10.017.

Golpe R, Esteban C, Figueira GonCalves JM, Amado Diago CA, Blanco Cid N, Aramburu A, et al. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease. Pulmonology. 2020. DOI:10.1016/j.pulmoe.2020.10.008.

Lacasse Y, Sériès F, Corbeil F, Baltzan M, Paradis B, Simão P, et al. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2020; 383(12): 1129-1138. DOI:10.1056/NEJMoa2013219.

Perez TA, Castillo EG, Ancochea J, Sanz MTP, Almagro P, Camblor PM, et al. Sex differences in COPD outcome in 5,355 women with COPD: A new analysis of the 3CIA study. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.1243.

Ruiz Iturriaga LA, Serrano Fernandez L, Martinez Indart L, Gomez Bonilla A, Artaraz Ereno A, Andia Iturrate J, et al. Differences in prognosis and outcome in patients with pneumococcal pneumonia and new onset atrial arrhythmia: impact of the time and duration of the arrhythmia. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.1777.

Bronte Moreno O, Aburto M, Urrutia A, Jaca C, Iciar Arrizubieta M, Begone Salinas M, et al. Study of IPF relatives as a method of early diagnosis of ILD disease. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.447.

Aramburu Ojembarrena A, Anton A, Javier Moraza F, Chasco L, Jodar A, Gorordo M, et al. Should anxiety and depression be more deeply researched in COPD?. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.108.

Bermudo Peloche G, Suarez Cuartin G, Ortega PR, Rodriguez Portal JA, Sauleda J, Nunez B, et al. Preserved Forced Vital Capacity is not Always Representing Early IPF. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.765.

Garcia Castillo E, Alonso Perez T, Ancochea Bermudez J, Pastor Sanz MT, Pablo De Torres J, Lamprecht B, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.966.

Javier Moraza F, Garcia P, Aramburu A, Sancho F, Chasco L, Antonio Gutierrez J, et al. Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.2664.

Esteban Gonzalez C, Aramburu A, Anton Ladislao A, Chasco L, Javier Moraza F, Aizpiri S, et al. Description of the COPD patients free of suffering severe exacerbations. Ten-year follow up of a cohort. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.1054.

Herrero FS, Iturriaga L, Clemente MMG, Yandiola P, Serrano RG, Fernandez LS, et al. Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.3091.

Alif S, Benke G, Kromhout H, Kogevinas M, Jarvis D, Le Moual N, et al. Occupational Exposures and Incidence of ASTHMA Over Two Decades in the ECRHS. Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.3141.

Gall XM, Ortega JD, Erquicia SP, Lopez CC, Panadero CJM, Ruiz GM, et al. Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE). Eur Resp J. 2020; 56. DOI:10.1183/13993003.congress-2020.2622.

Jimenez D, Agusti A, Monreal M, Otero R, Huisman MV, Lobo JL, et al. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease. Clin Cardiol. 2019; 42(3): 346-351. DOI:10.1002/clc.23161.

Mastroiacovo D, Dentali F, di Micco P, Maestre A, Jimenez D, Soler S, et al. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry. Eur Resp J. 2019; 53(2). DOI:10.1183/13993003.01677-2018.

de Miguel Diez J, Lopez Andres A, Jimenez Trujillo I, Hernandez Barrera V, Jimenez Garcia R, Lorenzo A, et al. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry. Eur J Intern Med. 2019; 59: 46-52. DOI:10.1016/j.ejim.2018.08.001.

Barco S, Klok FA, Mahe I, Marchena PJ, Ballaz A, Rubio CM, et al. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res. 2019; 173: 166-171. DOI:10.1016/j.thromres.2018.09.056.

Herrero EP, Gutiérrez SG, Ladislao AA, Salmerón PP, Corral MJM, Unzueta MIG, et al. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations. Emergencias. 2019; 31(1): 21-26

Almagro P, Martínez Camblor P, Miravitlles M, Rodríguez Carballeira M, Navarro A, Lamprecht B, et al. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study. COPD J Chronic Obstructive Pulm Dis. 2019; 16(1): 8-17. DOI:10.1080/15412555.2018.1484440.

Urrutia I, Delgado J, Domínguez Ortega J, Mascarós E, Pérez M, Resler G, et al. Clinical factors associated with the overuse of asthma rescue medication. J Invest Allergol Clin Immunol. 2019; 30(1): 42-48. DOI:10.18176/jiaci.0387.

Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, et al. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study. J Allergy Clin Immunol-Pract. 2019; 7(7): 2277-2277. DOI:10.1016/j.jaip.2019.01.017.

Espana PP, Uranga A, Alberto Ruiz L, Maria Quintana J, Bilbao A, Aramburu A, et al. Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001-2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain). Vaccine. 2019; 37(29): 3840-3848. DOI:10.1016/j.vaccine.2019.05.052.

Olivieri M, Murgia N, Carsin A, Heinrich J, Benke G, Bono R, et al. Effects of smoking bans on passive smoking exposure at work and at home. The European Community respiratory health survey. Indoor Air. 2019; 29(4): 670-679. DOI:10.1111/ina.12556.

Fernandez Fabrellas E, Molina M, Soriano JB, Rodriguez Portal JA, Ancochea J, Valenzuela C, et al. Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry. Respir Res. 2019; 20. DOI:10.1186/s12931-019-1084-0.

Flexeder C, Zock J, Jarvis D, Verlato G, Olivieri M, Benke G, et al. Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey. Respir Res. 2019; 20(1). DOI:10.1186/s12931-019-0996-z.

Pesce G, Marcon A, Calciano L, Perret JL, Abramson MJ, Bono R, et al. Time and age trends in smoking cessation in Europe. PLoS One. 2019; 14(2). DOI:10.1371/journal.pone.0211976.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Jorge Marcos P, Abdalla MI, et al. An international perspective on hospitalized patients with viral community-acquired pneumonia. Eur J Intern Med. 2019; 60: 54-70. DOI:10.1016/j.ejim.2018.10.020.

Sanz F, Ruiz Iturriaga LA, Garcia Clemente MM, Espana Yandiola PP, Serrano Fernandez L, Uranga Echeverria A, et al. Streptococcus Pneumoniae Serotype Determine Cardiac Complications During Invasive Pneumococcal Pneumonia. Am J Respir Crit Care Med. 2019; 199

Perez de Llano L, Martinez Moragon E, Plaza Moral V, Trisan Alonso A, Almonacid Sanchez C, Javier Callejas F, et al. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study. Respir Med. 2019; 151: 49-54. DOI:10.1016/j.rmed.2019.03.006.

Jose Legarreta M, Garcia Gutierrez S, Maria Quintana J, Martinez Tapias J, Ruiz A, Briones E, et al. A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease. JMIR Med Inf. 2019; 7(2): 102-113. DOI:10.2196/10773.

Lytras T, Kogevinas M, Kromhout H, Carsin A, Maria Anto J, Bentouhami H, et al. Occupational exposures and incidence of chronic bronchitis and related symptoms over two decades: the European Community Respiratory Health Survey. Occup Environ Med. 2019; 76(4): 222-229. DOI:10.1136/oemed-2018-105274.

Perez de Llano L, Luis Garcia Rivero J, Urrutia I, Martinez Moragon E, Ramos J, Cebollero P, et al. A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy. J Allergy Clin Immunol-Pract. 2019; 7(4): 1214-1214. DOI:10.1016/j.jaip.2018.10.017.

Aramburu A, Arostegui I, Moraza J, Barrio I, Aburto M, Garcia Loizaga A, et al. COPD classification models and mortality prediction capacity. Int J COPD. 2019; 14: 605-613. DOI:10.2147/COPD.S184695.

Carsin A, Fuertes E, Schaffner E, Jarvis D, Anto JM, Heinrich J, et al. Restrictive spirometry pattern is associated with low physical activity levels. A population based international study. Respir Med. 2019; 146: 116-123. DOI:10.1016/j.rmed.2018.11.017.

Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, et al. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients. Clin Infect Dis. 2019; 68(9): 1482-1493. DOI:10.1093/cid/ciy723.

Ruiz LA, Serrano L, Espana PP, Martinez Indart L, Gomez A, Uranga A, et al. Factors influencing long-term survival after hospitalization with pneumococcal pneumonia. J Infect. 2019; 79(6): 542-549. DOI:10.1016/j.jinf.2019.10.024.

Marin Barrera L, Muñoz Martin AJ, Rios Herranz E, Garcia Escobar I, Beato C, Font C, et al. A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study. Cancers (Basel). 2019; 12(1). DOI:10.3390/cancers12010075.

Fuertes E, Carsin AE, Garcia Larsen V, Guerra S, Pin I, Leynaert B, et al. The role of C-reactive protein levels on the association of physical activity with lung function in adults. PLoS One. 2019; 14(9). DOI:10.1371/journal.pone.0222578.

Menéndez R, Méndez R, Aldás I, Reyes S, Gonzalez Jimenez P, España PP, et al. Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers. Chest. 2019; 156(6): 1080-1091. DOI:10.1016/j.chest.2019.06.040.

Riera Mestre A, Mora Luján JM, Trujillo Santos J, Del Toro J, Nieto JA, Pedrajas JM, et al. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. Orphanet J Rare Dis. 2019; 14(1): 196-196. DOI:10.1186/s13023-019-1172-8.

Artaraz A, Uranga A, Chasco L, Garcia P, Aguirre U, Maria Quintana J, et al. Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA4535.

Bronte Moreno O, Aburto M, Chasco L, Arrizubieta I, Gorordo I, Altube L, et al. Evaluation of the palliative criteria in idiopathic pulmonary fibrosis. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA1732.

Horner A, Almagro P, Soriano JB, Kaiser B, Martinez Camblor P, Lang D, et al. Risk charts of five-year mortality in COPD patients. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA3322.

Esteban C, Esteban Aizpiri C, Aramburu A, Javier Moraza F, Sancho F, Dolores Tovar M, et al. Telehealth and machine learning for COPD patient care. Int J Integr Care. 2019; 19(1). DOI:10.5334/ijic.s3225.

Aramburu Ojembarrena A, Chasco Eguilaz L, Anton Ladislado A, Moraza Cortes FJ, Aburto Barrenechea M, Aizpiri Rivero S, et al. Influence of changes in physical activity (PA) and exercise capacity on mortality and quality of life (QL) in COPD. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA3893.

Bronte Moreno O, Dorado Arenas S, Pascual Erquicia S, Urrutia Landa I, Espana Yandiola PP, Arrizubieta Basterrechea MI, et al. Benefits from Tele-asthma management programme. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA2717.

Chasco Eguilaz L, Ballaz Quincoces A, Uranga Echeverria A, Aramburu Ojembarrena A, Zabala Hernandez T, Artaraz Ereno A, et al. Thromboprophylaxis (TP) in Pulmonology department in Galdakao-Usansolo Hospital. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA1465.

Fernandez A, Sanchez R, Pastor M, Bustamante V, Galaz B, Sancho C, et al. Impact of telemonitoring on patients with advanced chronic obstructive pulmonary disease. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA5228.

Ruiz Iturriaga LA, Serrano Fernandez L, Martinez Indart L, Gomez Bonilla A, Gonzalez Quero B, Artaraz Ereno A, et al. Long - term mortality in patients with pneumococcal and legionella pneumonia. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA4542.

Aliberti S, Cook GS, Babu BL, Reyes LF, Rodriguez AH, Sanz F, et al. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. J Infect. 2019; 79(4): 300-311. DOI:10.1016/j.jinf.2019.07.004.

Markevych I, Fuertes E, Marcon A, Dadvand P, Nowak D, Aymerich JG, et al. Residential greenness and lung function in a prospective cohort of European adults: The ECRHS study. Eur Resp J. 2019; 54(63). DOI:10.1183/13993003.congress-2019.PA4422.

Jara Palomares L, Alfonso M, Maestre A, Jimenez D, Garcia Bragado F, Font C, et al. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years. Sci Rep. 2019; 9(1). DOI:10.1038/s41598-019-55213-8.

Eguilaz LC, Quincoces AB, Reyes RL, Guerrero AR, Guarch CJ, Arciniegas AM, et al. Inter-observer correlation in detection of pulmonary hypertension (PH) after an acute pulmonary embolism (PE). Eur Resp J. 2019; 54. DOI:10.1183/13993003.congress-2019.PA1446.

Charroalde AM, Mozo PC, Campos JGS, Jorge AM, Gonzalez I. Omalizumab in allergic and non-allergic patients: results of FENOMA study. Eur Resp J. 2019; 54. DOI:10.1183/13993003.congress-2019.PA542.

Quezada A, PorresAguilar M, Jimenez D, Bikdeli B, Moores L, Aramberri M, et al. Systolic Blood Pressure and Mortality in Acute Symptomatic Pulmonary Embolism. Thromb Res. 2019; 182: 7-7. DOI:10.1016/j.thromes.2019.09.020.

Quezada CA, Bikdeli B, Barrios D, Morillo R, Nieto R, Chiluiza D, et al. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism. Thromb Res. 2018; 164: 40-44. DOI:10.1016/j.thromres.2018.02.140.

Kuperman A, López Reyes R, Bosco L-SJ, Lorenzo A, José B, Farge Bancel D, et al. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism. J Thromb Thrombolysis. 2018; 45(3): 360-368. DOI:10.1007/s11239-018-1610-9.

Uranga A, Quintana JM, Aguirre U, Artaraz A, Diez R, Pascual S, et al. Predicting 1-year mortality after hospitalization for community-acquired pneumonia. PLoS One. 2018; 13(2). DOI:10.1371/journal.pone.0192750.

Tufano A, Ageno W, Di Micco P, Niglio A, Rosa V, Ballaz A, et al. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thromb Res. 2018; 164: 69-74. DOI:10.1016/j.thromres.2018.02.143.

Chai Adisaksopha C, Iorio A, Crowther MA, de Miguel J, Salgado E, Zdraveska M, et al. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Am J Med. 2018; 131(4): 430-437. DOI:10.1016/j.amjmed.2017.11.042.

Esteban C, Castro Acosta A, Alvarez Martínez CJ, Capelastegui A, López Campos JL, Pozo Rodriguez F. Predictors of one-year mortality after hospitalization for an exacerbation of COPD. BMC Pulm Med. 2018; 18(1): 18-18. DOI:10.1186/s12890-018-0574-z.

Suárez Varela MM, Llopis A, Fernandez Fabrellas E, Sanz F, Perez Lozano MJ, Martin V, et al. Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain. J Asthma. 2018; 55(4): 391-401. DOI:10.1080/02770903.2017.1332204.

Sanz F, Morales Varela M, Fernández E, Force L, Pérez Lozano MJ, Martín V, et al. A Composite of Functional Status and Pneumonia Severity Index Improves the Prediction of Pneumonia Mortality in Older Patients. J Gen Intern Med. 2018; 33(4): 437-444. DOI:10.1007/s11606-017-4267-8.

Godoy P, Castilla J, Soldevila N, Mayoral JM, Toledo D, Martín V, et al. Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly. Eur J Public Health. 2018; 28(1): 150-155. DOI:10.1093/eurpub/ckx130.

Casado I, Domínguez Á, Toledo D, Chamorro J, Astray J, Egurrola M, et al. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study. CMAJ. 2018; 190(1): 3-12. DOI:10.1503/cmaj.170910.

Uranga A, España PP. Long-term Mortality in Community-acquired Pneumonia. Arch Bronconeumol. 2018; 54(8): 412-413. DOI:10.1016/j.arbres.2017.12.019.

Guerra B, Haile SR, Lamprecht B, Ramírez AS, Martinez Camblor P, Kaiser B, et al. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease. BMC Med. 2018; 16(1): 33-33. DOI:10.1186/s12916-018-1013-y.

Soler Cataluña JJ, Puente Maestu L, Román Rodríguez M, Esteban C, Gea J, Bernabeu Mora R, et al. Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice. Arch Bronconeumol. 2018; 54(9): 467-475. DOI:10.1016/j.arbres.2018.01.016.

Fuertes E, Carsin A-E, Antó JM, Bono R, Corsico AG, Demoly P, et al. Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study. Thorax. 2018; 73(4): 376-384. DOI:10.1136/thoraxjnl-2017-210947.

Martínez Rivera C, Crespo A, Pinedo Sierra C, García Rivero JL, Pallarés Sanmartín A, Marina Malanda N, et al. Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations. Respir Med. 2018; 135: 22-28. DOI:10.1016/j.rmed.2017.12.013.

Jarvis D, Newson R, Janson C, Corsico A, Heinrich J, Anto JM, et al. Prevalence of asthma-like symptoms with ageing. Thorax. 2018; 73(1): 37-48. DOI:10.1136/thoraxjnl-2016-209596.

Lønnebotn M, Svanes C, Igland J, Franklin KA, Accordini S, Benediktsdóttir B, et al. Body silhouettes as a tool to reflect obesity in the past. PLoS One. 2018; 13(4). DOI:10.1371/journal.pone.0195697.

Dellas C, Lobo JL, Rivas A, Ballaz A, Portillo AK, Nieto R, et al. Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT. Int J Cardiol. 2018; 265: 223-228. DOI:10.1016/j.ijcard.2018.04.066.

Marcon A, Locatelli F, Keidel D, Beckmeyer Borowko AB, Cerveri I, Dharmage SC, et al. Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study. Thorax. 2018; 73(9): 825-832. DOI:10.1136/thoraxjnl-2017-211289.

Svanes Ø, Bertelsen RJ, Lygre SHL, Carsin AE, Antó JM, Forsberg B, et al. Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction. Am J Respir Crit Care Med. 2018; 197(9): 1157-1163. DOI:10.1164/rccm.201706-1311OC.

Toledo D, Soldevila N, Torner N, Pérez Lozano MJ, Espejo E, Navarro G, et al. Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions. Bmj Open. 2018; 8(3). DOI:10.1136/bmjopen-2017-020243.

Lytras T, Kogevinas M, Kromhout H, Carsin AE, Antó JM, Bentouhami H, et al. Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey. Thorax. 2018; 73(11): 1008-1015. DOI:10.1136/thoraxjnl-2017-211158.

Accordini S, Calciano L, Johannessen A, Portas L, Benediktsdóttir B, Bertelsen RJ, et al. A three-generation study on the association of tobacco smoking with asthma. Int J Epidemiol. 2018; 47(4): 1106-1117. DOI:10.1093/ije/dyy031.

de la Rosa Carrillo D, Navarro Rolon A, Girón Moreno RM, Montull Veiga B, Olveira Fuster C, Padilla Galo A, et al. Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis. Respiration. 2018; 96(5): 406-416. DOI:10.1159/000489935.

Mendez R, Menendez R, Cilloniz C, Amara Elori I, Amaro R, Gonzalez P, et al. Initial inflammatory profile in community-acquired pneumonia depends on time since onset of symptoms. Am J Respir Crit Care Med. 2018; 198(3): 370-378. DOI:10.1164/rccm.201709-1908OC.

Fuertes E, Markevych I, Jarvis D, Vienneau D, de Hoogh K, Antó JM, et al. Residential air pollution does not modify the positive association between physical activity and lung function in current smokers in the ECRHS study. Environ Int. 2018; 120: 364-372. DOI:10.1016/j.envint.2018.07.032.

Izquierdo JL, Miravitlles M, Esquinas C, Pérez M, Calle M, López Campos JL, et al. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes. Arch Bronconeumol. 2018; 54(11): 559-567. DOI:10.1016/j.arbres.2018.03.021.

Quirós S, de la Rosa D, Uranga A, Madero R, Amaro R, Bruguera N, et al. Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey. Arch Bronconeumol. 2018; 54(10): 510-517. DOI:10.1016/j.arbres.2018.04.004.

Iturriaga L, Fernandez LS, Martinez Indart L, Bonilla AG, Ereno AA, Quero BG, et al. RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA. Eur Resp J. 2018; 52(62). DOI:10.1183/13993003.congress-2018.PA2631.

Fernandez LS, Iturriaga L, Martinez Indart L, Quero BG, Ereno AA, Ojembarrena AA, et al. INCIDENCE AND RISK FACTORS FOR NEW ATRIAL ARRHYTMIA IN PNEUMOCOCCAL PNEUMONIA. Eur Resp J. 2018; 52(62). DOI:10.1183/13993003.congress-2018.PA2638.

Bernaola M, Camino ME, Bernaola G, Vera A, Bartha I, Jimeno L, et al. Occupational rhinoconjunctivitis and asthma caused by allergy to buckwheat flour. Allergy. 2018; 73: 381-382

Weinberg I, Giri J, Kolluri R, Arcelus JI, Falgá C, Soler S, et al. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry. J Thromb Thrombolysis. 2018; 46(4): 551-558. DOI:10.1007/s11239-018-1736-9.

Bikdeli B, Lobo JL, Jiménez D, Green P, Fernández Capitán C, Bura Riviere A, et al. Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry. J Am Heart Assoc. 2018; 7(17). DOI:10.1161/JAHA.118.009042.

Moustafa F, Pesavento R, di Micco P, González Martínez J, Quintavalla R, Peris M-L, et al. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants. Clin Pharmacol Ther. 2018; 103(4): 684-691. DOI:10.1002/cpt.781.

Fernandez Sierra MA, Rueda Domingo MT, Rodriguez Aguila MM, Perez Lozano MJ, Force L, Fernandez Villa T, et al. Adaptation of antibiotic treatment to clinical practice guidelines in patients aged >= 65 years hospitalised due to community-acquired pneumonia. Epidemiol Infect. 2018; 146(14). DOI:10.1017/S0950268818002121.

Carsin AE, Keidel D, Fuertes E, Imboden M, Weyler J, Nowak D, et al. Physical activity and incidence of restrictive spirometry pattern in adults. Eur Resp J. 2018; 52(62). DOI:10.1183/13993003.congress-2018.PA5289.

Fuertes E, Carsin AE, Larsen VG, Guerra S, Pin I, Leynaert B, et al. Mediation analysis of CRP on the association of physical activity with FEV1 and FVC: the ECRHS study. Eur Resp J. 2018; 52(62). DOI:10.1183/13993003.congress-2018.PA4483.

Pesce G, Triebner K, Van der Plaat D, Courbon D, Marcon A, Accordini S, et al. Low dehydroepiandrosterone sulfate (DHEA-S) is associated with worse lung function in women. Eur Resp J. 2018; 52(62). DOI:10.1183/13993003.congress-2018.PA2280.

Horner A, Almagro P, Soriano JB, Kaiser B, Martinez Camblor P, Lang D, et al. Risk charts of five-year mortality in COPD patients*. Wien Klin Wochen. 2018; 130(19-20): 608-609

Fuertes E, Carsin AE, Garcia Larsen V, Guerra S, Pin I, Leynaert B, et al. IS THE ASSOCIATION OF PHYSICAL ACTIVITY WITH FEV1 AND FVC PARTIALLY MEDIATED BY C-REACTIVE PROTEIN LEVELS?: THE ECRHS STUDY. Thorax. 2018; 73(4): 229-230. DOI:10.1136/thorax-2018-212555.393.

Tesis del grupo

Autor/a: Sandra Dorado Arenas. Título: "Evaluación clínica, económica y de satisfacción de una red asistencial de asma. Estrategia coordinada y multidisciplinar entre atención primaria y neumología". Directores/as: Dr. José María Quintana López, Dra. Isabel Inés Urrutia Landa.

Autor/a: Silvia Pascual Erquicia . Título: "El efecto de la actividad física en la calidad de vida de pacientes con asma en el ECRHS". Director/a: Dra. Isabel Inés Urrutia Landa.

© 2022 IIS Biocruces Bizkaia